Stock OSL ONCOSIL MEDICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News OncoSil Medical Limited

Equities

OSL

AU000000OSL3

Market Closed - Australian S.E.
Other stock markets
 02:10:25 2024-07-12 am EDT 		5-day change 1st Jan Change
0.007 AUD 0.00% Intraday chart for OncoSil Medical Limited +16.67% -22.22%
Jun. 11 OncoSil Medical Treats Fifth Pancreatic Cancer Patient with Proprietary Device MT
Jun. 03 Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
OncoSil Medical Treats Fifth Pancreatic Cancer Patient with Proprietary Device
MT
Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device
MT
Oncosil Medical Enters Distribution Agreement with Abdulla Fouad Group for Saudi Arabia
MT
OncoSil Medical Raises AU$5.3 Million under Entitlement Offer
MT
OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial
MT
OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device
MT
OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study
MT
OncoSil Medical Obtains Device Reimbursement Approval in UK
MT
First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device
MT
Rights Issue: 1 new share @ 0.005 AUD for 2 existing shares
FA
Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus
MT
Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer
MT
OncoSil Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade
MT
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%
MT
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%
MT
OncoSil Medical Receives AU$1.1 Million R&D Tax Rebate
MT
First Patient Treated in OncoSil Medical's Pancreatic Cancer Drug Trial
MT
Oncosil Medical Limited Elects Gabrielle Liberatore as Director
CI
Australian Shares Rise on Expectations of Easing October CPI
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OSL Stock
  4. News OncoSil Medical Limited